These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 238866)
21. Suppressor T cells arising in mice undergoing a graft-vs-host response. Pickel K; Hoffmann MK J Immunol; 1977 Feb; 118(2):653-6. PubMed ID: 14213 [TBL] [Abstract][Full Text] [Related]
22. Mls-1a-induced peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras. Modification of T cell repertoire associated with active suppression and permanent presentation of host antigens. Miconnet I; Bruley-Rosset M; Halle-Pannenko O J Immunol; 1992 Jun; 148(12):3706-13. PubMed ID: 1534822 [TBL] [Abstract][Full Text] [Related]
23. Strain difference in the radiosensitivity of immunocompetent cells and its influence on the residual host-vs-graft reaction in lethally irradiated mice grafted with semiallogeneic bone marrow. Sado T; Kamisaku H; Kubo E J Immunol; 1985 Feb; 134(2):704-10. PubMed ID: 3880789 [TBL] [Abstract][Full Text] [Related]
24. In vitro immune response to the 2,4,6-trinitrophenyl determinant in aged C57BL/6J mice:changes in the humoral immune response to, avidity for the TNP determinant and responsiveness to LPS effect with aging. Kishimoto S; Takahama T; Mizumachi H J Immunol; 1976 Feb; 116(2):294-300. PubMed ID: 55434 [TBL] [Abstract][Full Text] [Related]
25. Matching of chemotherapy to mouse strain and lymphoid tumor type to prevent tumor-induced suppression of specific T- and B-cell functions. Faanes RB; Merluzzi VJ; Williams N; Tarnowski GS; Ralph P Cancer Res; 1979 Nov; 39(11):4564-74. PubMed ID: 315269 [TBL] [Abstract][Full Text] [Related]
26. Mutual recognition of parental and F1 lymphocytes. II. Analysis of graft-vs-host-induced suppressor cell activity for T cell-mediated lympholysis to trinitrophenyl self and alloantigens. Polisson RP; Shearer GM J Immunol; 1980 Oct; 125(4):1865-61. PubMed ID: 6967920 [TBL] [Abstract][Full Text] [Related]
27. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD. Pals ST; Radaszkiewicz T; Gleichmann E J Immunol; 1984 Apr; 132(4):1669-78. PubMed ID: 6230390 [TBL] [Abstract][Full Text] [Related]
28. The expression of theta-like antigen by rat peripheral lymphocytes: serologic and functional studies. Douglas TC; Dowsett AP J Immunol; 1975 Jul; 115(1):283-8. PubMed ID: 1151060 [TBL] [Abstract][Full Text] [Related]
29. Immunologic induction of reticulum cell sarcoma: donor-type lymphomas in the graft-versus-host model. Gleichmann E; Peters K; Lattmann E; Gleichmann H Eur J Immunol; 1976 Jun; 5(6):406-12. PubMed ID: 10170 [TBL] [Abstract][Full Text] [Related]
30. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice. Peres A; Nestel FP; Seemayer TA; Lapp WS J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120 [TBL] [Abstract][Full Text] [Related]
31. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice. Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578 [TBL] [Abstract][Full Text] [Related]
32. Studies about induction of resistance to the reaction of grafts against their host. Sula K; Nouza K Czech Med; 1985; 8(1):1-11. PubMed ID: 3922714 [TBL] [Abstract][Full Text] [Related]
33. Recovery of T cell populations after acute graft-vs-host reaction. Hakim FT; Payne S; Shearer GM J Immunol; 1994 Jan; 152(1):58-64. PubMed ID: 8254206 [TBL] [Abstract][Full Text] [Related]
34. Long-term immunologic tolerance induction in chimeric mice after bone marrow transplantation across major histocompatibility barriers: persistent or redeveloping immunologic responsiveness after prolonged survival. Sugiura K; Yasumizu R; Iwai H; Inaba MM; Toki J; Ogura M; Hara I; Good RA; Ikehara S Thymus; 1991 Nov; 18(3):137-53. PubMed ID: 1838450 [TBL] [Abstract][Full Text] [Related]
35. Immunosuppression of normal lymphoid cells by serum from mice undergoing chronic graft-vs-host disease. McMaster R; Levy JG J Immunol; 1975 Nov; 115(5):1400-3. PubMed ID: 240891 [TBL] [Abstract][Full Text] [Related]
36. Development of tumors as a result of graft-versus-host reaction. Cornelius EA Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858 [No Abstract] [Full Text] [Related]
37. Immunomodulation of GvH reaction in mice by Listeria monocytogenes. Rózalska B Arch Immunol Ther Exp (Warsz); 1987; 35(3):381-8. PubMed ID: 3128245 [TBL] [Abstract][Full Text] [Related]
38. The graft-versus-host reaction and immune function. IV. B cell functional defect associated with a depletion of splenic colony-forming units in marrow of graft-versus-host-reactive mice. Seddik M; Seemayer TA; Lapp WS Transplantation; 1986 Feb; 41(2):242-7. PubMed ID: 3511585 [TBL] [Abstract][Full Text] [Related]
39. Involvement of IFN-gamma and transforming growth factor-beta in graft-vs-host reaction-associated immunosuppression. Huchet R; Bruley-Rosset M; Mathiot C; Grandjon D; Halle-Pannenko O J Immunol; 1993 Mar; 150(6):2517-24. PubMed ID: 8450227 [TBL] [Abstract][Full Text] [Related]
40. Immune response of mice to the Thy-1.1 antigen: intra-H-2 mapping of the complementary Ir-Thy-1 loci. Zaleski MB; Klein J J Immunol; 1976 Sep; 117(3):814-7. PubMed ID: 1085312 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]